Bluejay Diagnostics Inc

Stock Chart, Company Information, and Scan Results

$1.61(as of Jul 17, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bluejay Diagnostics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$1.61
Ticker SymbolBJDX
ExchangeNasdaq
SectorHealthcare
IndustryMedical Devices
Employees7
CountyUSA
Market Cap$2.4M
EBIDTA-6.6M
10-Day Moving Average1.63
P/E Ratio-0.04
20-Day Moving Average1.62
Forward P/E Ratio0.00
50-Day Moving Average1.71
Earnings per Share277.20
200-Day Moving Average3.44
Profit Margin-862.82%
RSI45.26
Shares Outstanding1.5M
ATR0.12
52-Week High37.50
Volume25,330
52-Week Low1.46
Most Recent Support Level1.55
Book Value3.9M
Most Recent Resistance Level1.73
P/B Ratio0.07
Upper Keltner1.89
P/S Ratio1.19
Lower Keltner1.36
Debt-to-Equity Ratio1.89
Next Earnings DateUnknown
Cash Surplus1.8M
Next Ex-Dividend DateUnknown

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. Further, it is developing additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Bluejay Diagnostics Inc In Our Stock Scanner

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.